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Abstract
Background: We have previously obtained a clonal population of cells from human foreskin that is able to differentiate 
into mesodermal, ectodermal and endodermal progenies. It is of great interest to know whether these cells could be 
further differentiated into functional insulin-producing cells.
Results: Sixty-one single-cell-derived dermal fibroblast clones were established from human foreskin by limiting 
dilution culture. Of these, two clones could be differentiated into neuron-, adipocyte- or hepatocyte-like cells under 
certain culture conditions. In addition, those two clones were able to differentiate into islet-like clusters under 
pancreatic induction. Insulin, glucagon and somatostatin were detectable at the mRNA and protein levels after 
induction. Moreover, the islet-like clusters could release insulin in response to glucose in vitro.
Conclusions: This is the first study to demonstrate that dermal fibroblasts can differentiate into insulin-producing cells 
without genetic manipulation. This may offer a safer cell source for future stem cell-based therapies.
Background
Type 1 diabetes is an autoimmune disease that results in
the destruction of insulin-producing beta cells of the pan-
creas [1]. Increasing evidence suggests that islet trans-
plantation is a promising therapy for type 1 diabetes.
However, the limited supply of donors for pancreatic
islets severely limits this approach. The use of stem cells
to produce a new population of functional beta cells may
offer an alternative approach. Embryonic and adult stem
cells, including mesenchymal stem cells, hepatic oval
cells, adult pancreatic stem cells, and pancreatic-ducts
stem cells, are able to differentiate into insulin-secreting
cells in vitro and correct hyperglycemia in diabetic ani-
mal models [2-8].
Recent studies have demonstrated that dermal fibro-
blasts can be reprogrammed into embryonic stem cell-
like cells called induced pluripotent stem (iPS) cells by
introducing several stem cell-associated genes [9,10].
Tateishi et al. showed that dermal fibroblast-derived iPS
cells could also generate insulin secreting islet-like cells
[11], suggesting that iPS cells might be a potential cell
source for therapy. However, the genetic manipulation
involved could be problematic for future clinical applica-
tions.
In our previous study, we isolated, expanded and char-
acterized one clonal population from dermal fibroblasts,
which is able to differentiate into mesodermal, ectoder-
mal and endodermal progenies in vitro [12]. It is of great
interest to know whether these cells can be further differ-
entiated into functional insulin-producing cells. Thus,
the aim of this study was to establish clones from the
human dermis with greater multipotency, and to investi-
gate their potential to differentiate into pancreatic cells.
Results
Differentiation potential of single-cell derived dermal 
fibroblasts
In 70 of the 96-well plates (five plates/donor) seeded, 150
wells contained a single-cell-derived clone, but only 61
clones could survive and be continuously expanded. The
established clones exhibited a spindle-shaped morphol-
ogy without obvious differences between each clone (data
not shown). After 23-30 cell-doublings, the cells were cul-
tured in adipogenic, neurogenic and hepatogenic media
to determine their differentiation potential. As expected,
34% (21/62) of the clones exhibited adipogenic differenti-
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ation potential and were positive for Oil-Red O staining
after induction for 3 weeks (Figure 1A). Of these, only
two clones (Clones 27 and 45) showed neurogenic and
hepatogenic potential, as demonstrated by anti-NTR-3,
anti-GAP-43, anti-NF-M (Figure 1B), anti-ALB, and anti-
HNF-3β staining (Figure 1C). Therefore, these two clones
were termed multipotent dermal fibroblasts (MDFs).
Interestingly, none of the clones possessed neurogenic or
hepatogenic potential alone. These findings were consis-
tent with those observed in our previous study [12].
In vitro differentiation of MDFs into islet-like clusters
The existence of multipotent cells in cultured dermal
fibroblasts prompted us to check whether these cells
could be further differentiated into insulin producing
cells. Clones 27 and 45 (about 25 cell-doublings) were
treated with factors known to promote pancreatic differ-
entiation. Clone 46, which only possesses adipogenic
potential, was used as a control. After 14 days of induc-
tion, 20-30 (26 ± 1.7) of spherical cell clusters were
observed in each well of the six-well plate in Clones 27
and 45. However, cell clusters were not observed in Clone
46, or in the non-induced group (Figure 2A and 2B).
Immunofluorescent staining showed that the cell clusters
were positive for anti-insulin antibody staining (Figure
2C). No staining was observed in the isotypic control
group (data not shown). It has been reported that immu-
noreactivity of insulin in the cell clusters might due to the
uptake of insulin from culture media [13]. Therefore,
Figure 1 Differentiation potential of single-cell-derived dermal 
fibroblast clones. Cell were expanded for over 25 doublings and were 
then induced in differentiation media for the time intervals described 
in the Materials and Methods. Adipogenesis was evaluated by Oil Red 
O staining (A). Neurogenesis (B) was evaluated by anti-neurotensin re-
ceptor 3 (NTR, red color), anti-growth associated protein-43 (GAP-43, 
green color), and anti-neurofilament (NF-M, green color) staining. He-
patogenesis (C) was demonstrated by anti-albumin (ALB, green color) 
and anti-hepatic nuclear factor 3 beta (HNF-3β, green color) staining. 
Scale bars, 100 μm.
Figure 2 Differentiation of MDFs into islet-like clusters. Single-cell 
derived MDF clones (Clone 27 and 45) exhibited a spindle-shaped 
morphology in culture (A) and formed cell clusters after 14 days of pan-
creatic induction (B). The cell clusters were positive for anti-insulin (C, 
red color) and anti-C-peptide (D, red color) antibody staining. Single 
cells from cell clusters were also positive for anti-C-peptide (E, red col-
or) antibody staining. The nucleus is stained with DAPI (blue). Cell clus-
ters and positive antibody staining were not observed in Clone 46, 
with or without induction. Scale bars, 100 μm.Bi et al. BMC Cell Biology 2010, 11:46
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pancreatic differentiation was further confirmed by anti-
C-peptide antibody staining (Figure 2D). Positive staining
was observed in Clone 27 and 45. In addition, to rule out
the non-specific staining, cell clusters were picked out,
dissociated by typsin, and single cells were seeded on
cover glasses for 2 hours. Immunofluoresent staining for
anti-C-peptide was then repeated. Again, positive stain-
ing was observed in Clone 27 and 45, but not in Clone 46
(Figure 2E).
To characterize the pancreatic differentiation in more
detail, immunofluorescent staining of other pancreatic
endocrine hormones was performed, including glucagon,
which is synthesized and secreted from alpha cells of the
islets, and somatostatin, which is secreted from delta cells
of the islets. Interestingly, the cell clusters in the induced
Clones 27 and 45 were positive for anti-glucagon and
anti-somatostatin staining, whereas Clone 46 was not
(Figure 3A, B).
The gene expression profile analyzed by RT-PCR fur-
ther confirmed the pancreatic differentiation of MDFs.
As shown in Figure 4, pancreatic developmental tran-
scription factors, including PDX-1, ISL-1, NeuroD, Nkx
2.2, Ngn3 and PAX-4, were not detectable in the non-
induced cells. By contrast, these factors were upregulated
in induced MDFs (Clones 27 and 45). The islet-specific
hormones insulin and glucagon were also upregulated in
these cells after pancreatic induction, together with a glu-
cose transporter gene (Glut-2). By contrast, there was no
expression of pancreatic genes in Clone 46, with or with-
out induction. Vimentin, the mesoderm marker, was
expressed in all of the cells tested here. All of these data
support the concept that MDFs can be differentiated into
islet-like cells under pancreatic induction.
Release of insulin in response to glucose stimulation
To determine whether the differentiated MDFs (Clones
27 and 45) were responsive to glucose challenge, insulin
release after exposure to high glucose was measured
using human insulin ELISA kit. Clone 27 and 45 were
measured separately and each clone was repeated three
times. Similar pattern of glucose response were achieved
in both clones. Therefore, data from those two clones
were summarized in Figure 5. The insulin secretion was
gradually increased with the increase in glucose concen-
tration from 0 mM to 5.5 mM in differentiated MDFs.
However, secretion did not increase further at a higher
glucose concentration (10 mM). One-way ANOVA
showed significant differences between groups (p < 0.05).
Figure 3 Expression of glucagon and somatostatin (SOM) in 
MDFs derived islet-like clusters. Islet-like clusters derived from Clone 
27 and 45 after 14 days of pancreatic induction were positive for anti-
Glucagon (A) and anti-SOM (B) staining (red), but negative in Clone 46. 
Nuclei were stained with DAPI (blue). Scale bars, 100 μm.
Figure 4 Pancreatic gene expression in MDFs. Cells before (1) and 
after 14 days of pancreatic induction (2) were harvested and analyzed 
by RT-PCR. Human adult pancreatic tissue was used as a positive con-
trol. Only for Ngn3, RNA isolated from fetal pancreas was used as con-
trol.
Figure 5 Islet-like cell clusters release insulin in response to glu-
cose in vitro. After pancreatic induction, the amount of insulin in the 
culture media was measured by ELISA after the cells (clones 27 and 45) 
were exposed to different concentrations of glucose. One-way ANOVA 
showed significant differences between groups (p < 0.05). The aster-
isks denote a significant difference between two groups.Bi et al. BMC Cell Biology 2010, 11:46
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Comparing with non-stimulated group (0 mM), signifi-
cant differences (P < 0.05) were observed in the groups
with glucose stimulation at 1 mM or 5.5 mM, but not in
the other groups (0.1 mM, 0.5 mM, 10 mM). In addition,
significant differences were also observed in those two
groups (1 mM, 5.5 mM) comparing with the one stimu-
lated with glucose at 0.1 mM. These data indicate that
islet-like cell clusters derived from MDFs could secrete
insulin in response to glucose stimulation at a very lim-
ited level.
Discussion
Numerous studies have demonstrated the presence of
stem cells in the adult dermis [14,15]. Our previous study
revealed that dermal fibroblasts are a heterogeneous pop-
ulation that contains cells with variable differentiation
potential [12]. In the present study, we confirmed that a
small population of cells from human foreskin is multipo-
tent. These cells could be differentiated into neuron-, adi-
pocyte- and hepatocyte-like cells in the presence of
certain factors. More importantly, these cells could differ-
entiate into islet-like cells capable of expressing insulin,
glucagon and somatostatin after pancreatic induction. In
addition, the islet-like clusters could release insulin in
response to glucose in vitro.
Pancreatic differentiation of MDFs has been demon-
strated by the expression of pancreatic genes at the
mRNA (Figure 4) level. Although, immunoreactivity of
insulin was observed in the cell clusters after induction
(Figure 2C), it can not rule out the possibility that the
insulin is trapped in clusters, since the media contains
FBS/insulin [13]. By anti-C-peptide immunostaining, we
confirmed that induced cells do express insulin (Figure
2D, E). Unfortunately, the functional assay showed that
the islet-like cells released insulin in response to glucose
stimulation with limited ability (Figure 5). The low insulin
secretory capacity may be due to the loss of stem cell
properties during MDF expansion. We have found that
cells after 30 cell-doublings completely lose their multi-
potency (data not shown). Thus, the cells investigated in
this study (approximately 25 cell-doublings) were close to
their capacity. Optimal cell expansion conditions are
worth to be investigated to improve the pancreatic differ-
entiation ability. Meanwhile, the in vivo function of insu-
lin-producing cells is under investigation in diabetic
animals.
Vimentin is the marker of mensenchymal cells. The
MDFs express vimentin even after pancreatic induction
(Figure 4). Although there have been reports of epithelial-
to-mesenchymal transition (EMT) of pancreatic islet cells
and differentiation of such cells back to insulin-produc-
ing cells [16-18], it is hard to believe that skin epithelial
cells undergo EMT to differentiate into pancreatic cells.
Guo et al. reported that skin-derived precursors (SKPs)
from mouse, which express nestin but not vimentin,
could also be differentiated into insulin producing
cells[19], indicating that EMT is not likely the mecha-
nisms for differentiation of skin cells to pancreatic cells.
As we discussed previously, the relationship between
SKPs and the multipotent dermal fibroblasts in our study
is still unclear [12]. Nevertheless, it supports our findings
that skin contains multipotent cells that could be differ-
entiated into islet-like cells.
The finding that MDFs could give rise to cells of three
germ layers is surprising. Interestingly, similar types of
multipotent cells have been isolated from other adult tis-
sues, such as spermatogonial stem cells in the adult testis
[20] and very small embryonic-like (VSEL) stem cells in
the bone marrow [21]. Kucia et al. speculated that the
multipotent stem cells in adult tissues might be derived
from early embryonic cells that reside in different tissues
during developmental process and are maintained to the
adult stage [21]. It could be speculated that those MDFs
might be derived from residual undifferentiated cells in
the dermis. To further localize these cells in the dermis
and to enrich them from the pooled population, the char-
acteristics unique to these cells are under investigation.
Recent studies have demonstrated that the iPS cells
derived from reprogramming of dermal fibroblasts are
multipotent and could generate insulin secreting islet-like
cells [11]. The relationship between MDFs and iPS cells
should also be investigated. Kim et al. demonstrated that
the induction of iPS from stem cells seems to be easier
than that from differentiated cells [22]. One possibility is
that the reprogramming process might mainly occur in
MDFs rather than in the differentiated dermal fibroblasts.
Thus, only MDFs could selectively expand in culture.
Moreover, the number of reprogramming factors could
be reduced when using MDFs as a target. Further studies
are needed to answer these questions.
Conclusions
In summary, this is the first study to demonstrate that
multipotent dermal fibroblasts could be differentiated
into islet-like cells without genetic manipulation. This
approach might offer a safer cell source for future stem
cell-based therapies.
Methods
Derivation of single-cell derived clones from dermis
Single-cell derived clones were established according to
the method described by Chen et al. [12]. Briefly, fresh
human foreskin specimens were obtained from 14 donors
aged from 6 to 12 years who underwent a routine circum-
cision procedure at Shanghai Children's Hospital with
informed consent. The study was performed with
approval from the local ethics committee (Shanghai Jiao
Tong University School of Medicine, China). The single-Bi et al. BMC Cell Biology 2010, 11:46
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cell suspension was achieved after enzyme digestion and
filtration. The cells were then suspended in high-glucose
DMEM (DMEM-HG; Invitrogen Corporation, Carlsbad,
CA, USA), supplemented with 10% FBS (HyClone, Logan,
UT), 300 μg/m1 L-glutamine, 50 μg/ml vitamin C, 100 U/
ml penicillin and 100 μg/ml streptomycin (all from
Sigma, St Louis, MO, USA). The cells were then seeded in
96-well tissue culture plates (Falcon, Franklin Lakes, NT)
at a concentration of 2 cells/well (200 μl/well, five plates/
donor). After 24 h, the plates were scored under the
microscope. Wells containing only one cell were marked
for further analysis. The cells were kept in the original
culture medium at 37°C with 5% CO2. After 2-3 weeks,
the single-cell-derived clones were harvested and trans-
ferred to 24-well and six-well tissue culture plates (Fal-
con) for expansion. In total, 61 clones were established,
and their differentiation potential was analyzed.
Multilineage differentiation of single-cell derived clones
Single-cell-derived clones were analyzed for their capac-
ity to differentiate into adipocytes, neuron and hepato-
cytes. Each experiment was repeated at least three times
for cells from each clone.
Adipogenic differentiation
Adipogenic differentiation was performed as previously
described [12]. Briefly, cells were seeded at 1 × 103 cells/
cm2 in adipogenic medium for 3 weeks. Cells cultured in
the regular culture medium were used as a control. The
medium was changed every 3 days. Cells were stained
with Oil Red O reagent (Sigma) for 5 minutes after induc-
tion.
Neurogenic differentiation
Neurogenic differentiation was performed as previously
described [23]. Briefly, cells were seeded at 1 × 103 cells/
cm2 on fibronectin-coated dishes, incubated with sequen-
tial changes in neurogenic medium for up to 10 days.
Cells maintained in regular culture medium were used as
a control.
Hepatogenic differentiation
Hepatogenic differentiation was performed as described
by Schwartz et al. [24]. Cells were seeded at 4 × 103 cells/
cm2 on fibronectin-coated dishes, pre-induced for 10 h
followed by culturing with hepatogenic medium for up to
3 weeks. The medium was changed every 2 days. Cells
Table 1: Primers used in RT-PCR analysis
Gene Primer sequence Number of cycles Annealing 
temperature (°C)
Product size(bp)
Insulin Sense: 5'-GCCTTTGTGAACCAACACCTG -3'
Antisense: 5'-GTTGCAGTAGTTCTCCAGCTG -3'
35 67 261
Glucagon Sense: 5'-ATCTGGACTCCAGGCGTGCC -3'
Antisense: 5'-AGCAATGAATTCCTTGGCAG -3'
35 65 170
ISL-1 Sense: 5'-CAACAAACAAAACGCAAAAC -3'
Antisense: 5'-AAGTCAAACACAATCCCGA -3'
35 62 542
PDX-1 Sense: 5'-GTCCTGGAGGAGCCCAAC -3'
Antisense: 5'-GCAGTCCTGCTCAGGCTC -3'
35 65 360





















Abbreviations: ISL-1, islet-1 transcription factor; PDX-1, pancreatic duodenal homeobox-1; NeuroD, neurogenic differentiation; Ngn3, 
neurogenin 3; Nkx2.2, NK-2 family homeodomain transcription factor; Pax-4, paired box gene 4; Glut-2, glucose transporter 2.Bi et al. BMC Cell Biology 2010, 11:46
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maintained within the regular culture medium were used
as a control.
Pancreatic differentiation of multipotent dermal fibroblasts 
in vitro
To induce the multipotent dermal fibroblasts (MDFs) to
undergo pancreatic endocrine cell differentiation, the
cells were treated by sequential specification, commit-
ment and differentiation with factors known to promote
the expression of a beta cell-like phenotype, as previously
described [2,25-27]. Briefly, cells were plated at a density
of 10,000 cells/cm2 in the presence of DMEM-HG, 20%
FBS for 24 hours. On the next day, medium containing
DMEM-HG, 20% FBS and 10 ng/ml b-FGF (#233-FB-025;
R&D Systems, Minneapolis, MN) was added for another
24 hours. Endodermal specification was then induced by
exposure to medium containing DMEM-HG, 1% DMSO
(#D4540; Sigma), 100 mM butylated hydroxyanisole
(BHA, #B1253; Sigma), and 10 nM exendin-4 (#E7144;
Sigma) for 24 hours. Cells were washed three times, and
endodermal commitment was induced by exposure to
medium containing RPMI 1640 (#12633-012; Invitrogen),
11.1 mM glucose, 10% FBS, 1.0 mM sodium pyruvate, 10
mM Hepes (#H3375; Sigma),20 ng/ml b-FGF and 20 ng/
ml EGF (#236-EG-200; R&D Systems), and 10 nM exen-
din-4 for 4 days. Islet-like differentiation was subse-
quently induced by exposing the cells to medium
composed of RPMI 1640, 2.5 mM glucose, 10 mM Hepes,
10 mM nicotinamide (#N0636; Sigma), 100 pM HGF
(#H1404; R&D Systems), 10 nM exendin-4, and 2.0 nM
activin-A (#A4941; Sigma) for 5-7 days.
Immunofluorescent staining
To stain intracellular proteins, the cells were fixed in 4%
cold paraformaldehyde (Sigma) in phosphate-buffered
saline (PBS) for 15 minutes on chamber slides, and per-
meabilized with 0.25% Triton X-100 (Sigma) in PBS for
10 minutes. The blocking and diluent solutions com-
prised PBS, 1% BSA and 1% serum (Sigma) from the spe-
cies in which the secondary antibody was raised. The
fixed cells were blocked for 30 minutes, incubated
sequentially with the primary antibodies diluted in PBS at
4°C overnight, followed by incubation with secondary
antibodies. Cells exposed to isotypic antibodies were
used as controls. Nuclei were counterstained by DAPI (4',
6'-diamidino-2-phenylindole, Invitrogen). The primary
antibodies, including anti-neurotensin receptor 3 (NTR-
3, 1:100), anti-growth associated protein-43 (GAP-43,
1:100), anti-neurofilament (NF-M, 1:100), anti-hepatic
nuclear factor 3 beta (HNF-3β, 1:100), anti-albumin
(ALB, 1:100), anti-insulin (1:100), anti-C-peptide (1:100),
anti-glucagon (1:100) and anti-somatostatin (SOM,
1:100) were purchased from Santa Cruz Biotechnology.
Secondary antibodies, including anti-goat IgG (H+L),
anti-rabbit IgG (H+L), anti-mouse IgG (H+L) labeled
with Alexa Fluor 488 or Alexa Fluor 546 (1:1000 Molecu-
lar Probes, Invitrogen), were used according to the manu-
facturer's recommendations.
RT-PCR analysis
Total RNA was extracted with TRIzol (Invitrogen) and
reverse-transcribed into cDNA with an RT-PCR kit
(TaKaRa, Shiga, Japan). The primer sequences (all from
Sangon Technology Co., Shanghai, China), reaction con-
ditions and the sizes of each product are listed in Table 1.
The amplified products were separated on 1.5% agarose
gels and visualized with ethidium bromide. Human adult
pancreatic tissue was used as a positive control. Only for
Ngn3, which is not expressed in adult pancreas, RNA iso-
lated from fetal pancreas was used as control.
Glucose-regulated insulin secretion
To determine whether cells could respond to glucose in
vitro, the differentiated cells were pre-incubated for 4
hours at 37°C in Krebs-Ringer bicarbonate Hepes
(KRBH) buffer containing 118 mM sodium chloride, 4.7
mM potassium chloride, 1.1 mM potassium dihydrogen
phosphate, 25 mM sodium hydrogen carbonate, 3.4 mM
calcium chloride, 2.5 mM magnesium sulfate, 10 mM
Hepes and 2 mg/ml bovine serum albumin (BSA). For
high-glucose-induced insulin release, cells were incu-
bated in KRBH buffer supplemented with different con-
centrations of glucose (0-10 mM) together with 10 μM
tolbutamide (Sigma) for 2 hours at 37°C. The concentra-
tion of insulin secreted into the culture media was mea-
sured using an ultra-sensitive human insulin enzyme-
linked immunosorbent assay (ELISA) kit (Diagnostic Sys-
tems Laboratories, Webster, TX, USA). Cells were col-
lected and total protein was determined using the DC
protein assay system (Bio-Rad, Hercules, CA, USA). The
data are presented as secreted insulin/total protein (ng/
mg). Clone 27 and 45 were measured separately and each
clone was repeated three times.
Statistical analysis
Each experiment was repeated at least three times. All
data are presented as means ± standard deviation. The
data of insulin release after glucose stimulation were sub-
jected to one-way analysis of variance (ANOVA) using
the SPSS version 13.0, and the Student Newman-Keuls
test was used for multiple comparisons. P values less than
0.05 are interpreted as significant.
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